LD-2 disclosure · 1st Quarter - Report
ILLUMINA, INC.
via ILLUMINA, INC.
Client
- Name
- ILLUMINA, INC.
- Location
- California · United States of America
Registrant
- Firm
- ILLUMINA, INC.
- Description
- ​Sequencing and Array-based Solutions for Genetic Research, Clinical and Applied Markets.
- Location
- SAN DIEGO, California, United States of America
Lobbying activities
3 issuesHealth Issues
Public Law No: 117-328 (H.R. 2617-117th Congress): Consolidated Appropriations Act, 2023; General Discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, Centers for Disease Control and Prevention surveillance funding and National Institutes of Health funding General Discussions related to the Food and Drug Administration's regulation of diagnostics General Discussion related to Medicares payment system for clinical diagnostic laboratory services General Discussions related to the Cancer Moonshot Initiative General Discussions related to genomic surveillance and pandemic preparedness General Discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy
Lobbyistsmr BRIAN CHRISTOPHER TOOHEY · NICOLAS MAGALLANES
Covered position (NICOLAS MAGALLANES): Senior Advisor - House Republican Conference 2014-2105; Policy Advisor/Professional Staff Member - Rep. Lee Terry/Energy & Commerce Committee; 2012-2014; Legislative Correspondent/Legislative Aide - Sen. Lamar Alexander - 2010-2012
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Natl Security Council (NSC) · Office of Science & Technology Policy (OSTP) · Health & Human Services, Dept of (HHS) · Natl Science Foundation (NSF)
Government Issues
General Discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology
Lobbyistsmr BRIAN CHRISTOPHER TOOHEY · NICOLAS MAGALLANES